Parkinson's DiseaseNCT04994015
Parkinson's Foundation PD GENEration Genetic Registry
An observational study of Parkinson's Disease, run by Parkinson's Foundation at 70 sites in 3 countries.
Trial summary
Development of a central repository for PD-related genomic data for future research. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Parkinson's Disease
- What is being tested?
- Lab Assay for seven genetic variants for Parkinson's Disease
- Type of treatment
- Medical device
- How many people
- 35,382 participants
- Where
- 70 sitesin 3 countries
- Study dates
- 20 Dec 2020to 1 Jul 2027
- How long will I take part?
- 30 Days
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Any person with probable diagnosis of Parkinson's disease according to the Movement Disorders Society criteria.
Who may be able to join
- Study Population 1: PWP (open for recruitment)
- Meet Movement Disorder Society (MDS) Clinical Diagnostic Criteria for Parkinson's Disease: probable diagnosis.
- Willingness to undergo genetic testing, and choose to be informed of genetic testing results for GBA, LRRK2 and 5 additional PD related genes (SNCA, VPS35, PRKN, PINK-1, PARK7).
- Capacity to give full informed consent in writing or electronically, and have read and signed the informed consent forms (ICFs) based on site clinician's determination.
- Able to perform study activities (including completion of either online, in-person or paper surveys).
- Study Population 2: People at risk of developing PD (not open for recruitment)
- 1. Family members of Study Population 1 may be invited to participate in the study if confirmatory genetic testing is deemed necessary by the genetic testing laboratory.
Who cannot join
- Diagnosis of an atypical parkinsonian disorder (i.e., multiple system atrophy, progressive supranuclear palsy, dementia with Lewy bodies, corticobasal syndrome), including that due to medications, metabolic disorders, encephalitis, cerebrovascular disease, or normal pressure hydrocephalus.
- Individuals who have received a blood transfusion within the past 3 months.
- Individuals who have active hematologic malignancies such as lymphoma or leukemia.
- Individuals who have had a bone marrow transplant within the past 5 years.
- Under the age of 18
Trial locations and contacts
70 sites in 3 countries. Contact the study team or a site near you to ask about taking part.
70 sites in 3 countries
United States63 sites, 51 recruiting
- Recruiting
University of New Mexico
Albuquerque, New Mexico, 87106
Anna Tingin, ATingin@salud.unm.edu
Amanda Deligtisch, MD
- Active, not recruiting
University of Michigan
Ann Arbor, Michigan, 48109
- Recruiting
Morehouse College
Atlanta, Georgia, 30314
Tamiko Durham, tdurham@msm.edu
Chantale Branson, MD
- Recruiting
University of Colorado Anschutz
Aurora, Colorado, 80045
Janet Clarke, janet.clarke@cuanschutz.edu
Jeanne Feuerstein, MD
- Active, not recruiting
Aventura Neurology - Visionary Investigators Network
Aventura, Florida, 33180
- Recruiting
Johns Hopkins
Baltimore, Maryland, 21218
Shamera Willoughby, swillou5@jh.edu
Kelly Mills, MD
- Active, not recruiting
University of Alabama Birmingham
Birmingham, Alabama, 35294
- Recruiting
Parkinson's Disease & Movement Disorder Center of Boca Raton
Boca Raton, Florida, 33486
Carla Delgado, cdelgado@parkinsonscenter.org
Karina Weldon, kweldon@parkinsonscenter.org
- Recruiting
Massachusetts General Hospital (MGH)
Boston, Massachusetts, 02114
Chinyere Obase, cobasi@mgh.harvard.edu
Anne-Marie Wills, MD
- Active, not recruiting
BMC Community Hospital
Boston, Massachusetts, 02136
- Recruiting
Beth Israel Deaconess Medical Center (BIDMC)
Boston, Massachusetts, 02215
Mia Lewandowski, mlewand1@bidmc.harvard.edu
David Simon, MD
- Terminated
MD First Research
Chandler, Arizona, 85286
- Recruiting
University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, 27599
Hans Nettescheim, pdgenestudy@unc.edu
Claudia Testa, MD, PhD
- Recruiting
Medical University of South Carolina
Charleston, South Carolina, 29425
Sandra Wilson, wilsosan@musc.edu
Gonzalo Revuelta, DO
- Active, not recruiting
Atrium Health
Charlotte, North Carolina, 28207
- Recruiting
University of Illinois-Chicago
Chicago, Illinois, 60607
Lucia LeBlanc Perez, lleblanc@uic.edu
Yasaman Kianirad, MD
- Recruiting
Rush University
Chicago, Illinois, 60612
Marc Rosenbaum, Marc_Rosenbaum@rush.edu
Jacqueline Vanegas, Jacqueline_Vanegas@rush.edu
- Recruiting
University of Chicago
Chicago, Illinois, 60637
Hanna Lancerio, hlancerio@bsd.uchicago.edu
Tao Xie, MD, PhD
- Active, not recruiting
University of Cincinnati
Cincinnati, Ohio, 45221
- Recruiting
Case Western Reserve University
Cleveland, Ohio, 44106
Eileen Terrell, eileen.terrell@UHhospitals.org
Steven Gunzler, MD
- Recruiting
Cleveland Clinic
Cleveland, Ohio, 44195
Mollie Colan, colanm@ccf.org
Hubert Fernandez, MD
- Recruiting
University of Maryland
College Park, Maryland, 20742
Rebecca Weimer, rweimer@som.umaryland.edu
Lisa Shulman
- Recruiting
Ohio State University
Colombus, Ohio, 43210
Victoria Miller, Victoria.Miller@osumc.edu
Anna Warner, anna.warner@osumc.edu
- Recruiting
Northwestern University
Evanston, Illinois, 60208
Karen Williams, k-williams8@northwestern.edu
Monika Szela, monika.szela@northwestern.edu
- Recruiting
University of Connecticut
Farmington, Connecticut, 06030
Sheila Thurlow, thurlow@uchc.edu
Rodrigues Bernardo, MD, PhD
- Recruiting
University of Arkansas
Fayetteville, Arkansas, 72701
Kennetha Newman, newmankennethal@uams.edu
Rohit Dhall, MD
- Recruiting
University of Florida
Gainesville, Florida, 32611
Amanda Fessenden, amanda.fessenden@neurology.ufl.edu
Irene Andonia Malaty, MD
- Recruiting
Struthers Parkinson's Center - HealthPartners Park Nicollet
Golden Valley, Minnesota, 55427
Renee Rosenberg, renee.rosenberg@parknicollet.com
Martha Nance, MD
- Active, not recruiting
Hartford Healthcare
Hartford, Connecticut, 06066
- Recruiting
The Queen's Health System
Honolulu, Hawaii, 96813
Kenny Thai, kthai@queens.org
Michiko Bruno, MD
- Recruiting
Baylor College of Medicine
Houston, Texas, 77030
Silvia Onofre, silvia.onofre@bcm.edu
Fatima Chavez, fatima.chavez@bcm.edu
- Recruiting
The University of Texas Health Science Center at Houston
Houston, Texas, 77030
Christian Henry Jackson, Christian.B.HenryJackson@uth.tmc.edu
Shivika Chandra
- Active, not recruiting
Indiana University
Indianapolis, Indiana, 46202
- Recruiting
University of Iowa
Iowa City, Iowa, 52242
Heena Olalde, heena-olalde@uiowa.edu
Annie Killoran, MD, MS
- Recruiting
Evergreen Health
Kirkland, Washington, 98034
Nasir Hemat, nahemat@evergreenhealthcare.org
Pinky Agarwal, MD
- Recruiting
University of California San Diego (UCSD)
La Jolla, California, 92093
Lisa Solomon, 8588225873, ldamron@health.ucsd.edu
Irene Litvan, MD
- Recruiting
Cleveland Clinic Lou Ruvo Center for Brain Health
Las Vegas, Nevada, 89106
Liliana Dumitrescu, DUMITRL@ccf.org
Zoltan Mari
- Recruiting
University of Kansas
Lawrence, Kansas, 66045
Sarina Fay, sfay2@kumc.edu
Rajesh Pahwa, MD
- Recruiting
University of Kentucky
Lexington, Kentucky, 40506
Renee Wagner, rpwagn2@uky.edu
Tritia Yamasaki, MD, PhD
- Recruiting
University of Southern California
Los Angeles, California, 90033
Gita Itani, gita.itani@med.usc.edu
Katherine Wong, MD
- Recruiting
University of California Los Angeles
Los Angeles, California, 90095
Alexandra Shurlock, Ashurlock@mednet.ucla.edu
Jeff Bronstein, MD, PhD
- Recruiting
University of Miami
Miami, Florida, 33131
Melanie Suzette Sousa, mss379@med.miami.edu
Carlos Singer, MD
- Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
Victoria Ochotnicky, vochotnicky@mcw.edu
Kayla Grundman, kgrundman@mcw.edu
- Recruiting
Intermountain Health
Murray, Utah, 84107
Kenna Farnes, Kenna.Farnes@imail.org
Kathleen McKee, MD
- Recruiting
Vanderbilt University
Nashville, Tennessee, 37235
Jacqueline Harris, jacqueline.c.harris@vumc.org
Tom Davis, MD
- Active, not recruiting
Rutgers University
New Brunswick, New Jersey, 08854
- Active, not recruiting
New York University
New York, New York, 10017
- Recruiting
Mount Sinai
New York, New York, 10029
Maya Rawal, maya.rawal@mountsinai.org
Susan Bressman, MD
- Recruiting
Columbia University
New York, New York, 10033
Amy Arroyo, aa4399@cumc.columbia.edu
Julian Agin-Liebes, MD
- Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania, 19104
Neda Almassi, Neda.Almassi@pennmedicine.upenn.edu
Rebecca Williamson, MD
- Recruiting
Thomas Jefferson University
Philadelphia, Pennsylvania, 19144
Michelle Rochman, Michelle.Rochman@jefferson.edu
Tsao-Wei Liang, MD
- Recruiting
Barrow Neurological Institute
Phoenix, Arizona, 85013
Ruby Rendon, 602-406-4280, ruby.rendon@dignityhealth.org
Holly Shill, MD
- Recruiting
Allegheny Health Network
Pittsburgh, Pennsylvania, 15212
Maureen Boms, Maureen.Boms@ahn.org
Sushma Kola
- Not yet recruiting
Maine Medical Center
Portland, Maine, 04102
Michael Kleinmann
- Recruiting
Oregon Health and Science University
Portland, Oregon, 97239
Emily Leonard, PDResearch@ohsu.edu
Joseph Quinn, MD
- Recruiting
Stanford University
Redwood City, California, 94063
Michaela Pelta, pelta@stanford.edu
Hengameh Zahed
- Recruiting
Virginia Commonwealth University
Richmond, Virginia, 23284
Virginia Norris, virginia.norris@vcuhealth.org
Matthew Barrett, MD
- Recruiting
University of Rochester Medical Center
Rochester, New York, 14618
Jill Lowell, movement_research@urmc.rochester.edu
Blanca Y. Valdovinos, MD
- Recruiting
University of Texas at San Antonio
San Antonio, Texas, 78249
Carolyn Paiz, paizc@uthscsa.edu
Victoria Carranza, carranzav@uthscsa.edu
- Recruiting
University of California San Francisco (UCSF)
San Francisco, California, 94143
Aaron Daley, aaron.daley@ucsf.edu
Jill Ostrem, MD
- Recruiting
Louisiana State University
Shreveport, Louisiana, 71103
Ty Martinez, ty.martinez@lsuhs.edu
Elizabeth Disbrow, PhD
- Recruiting
Inland Northwest Research
Spokane, Washington, 99202
October Strange, ostrange@inwresearch.com
Jason Aldred, MD
- Active, not recruiting
Cleveland Clinic Weston
Weston, Florida, 33331
Canada4 sites, 3 recruiting
- Recruiting
University of Alberta
Edmonton, Alberta, T5J 4P6
Frances Cheung, fkcheung@ualberta.ca
Janis Miyasaki, MD
- Active, not recruiting
McGill University
Montreal, Quebec, H3A 0G4
- Recruiting
Toronto Western Hospital
Toronto, Ontario
Nazish Ahmed, nazish.ahmed@uhnresearch.ca
Connie Marras, MD, PhD
- Recruiting
University of British Columbia
Vancouver, British Columbia, V6T 1Z3
Sahib Dhaliwal, sahib.dhaliwal@ubc.ca
Silke Appel-Cresswell
Israel3 sites, 3 recruiting
- Recruiting
Shaare Zedek Medical Center
Jerusalem
Hadar Iluz, hadaril@szmc.org.il
Gilad Yahalom, MD
- Recruiting
Chaim Sheba Medical Center
Ramat Gan
Tal Bar Dor, Tal.Bardor@sheba.health.gov.il
Adi Saar, Adi.Saar@sheba.health.gov.il
- Recruiting
Tel Aviv Sourasky Medical Center
Tel Aviv, 64239
Haleli Sharir, halelis@tlvmc.gov.il
Meirav Kalish, meiravk@tlvmc.gov.il
About this study
Development of a central repository for PD-related genomic data for future research.
Read the detailed description
The purpose of this study is to develop a central repository for PD-related genomic data by individuals who consent to deposit their data and bank their residual DNA obtained through clinical genetic testing for future research use.
- Conditions
- Parkinson's Disease
- Being tested
- Lab Assay for seven genetic variants for Parkinson's Disease
- Keywords
- Genetics, Genetic Counseling, Whole Genome Sequencing
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Lab Assay for seven genetic variants for Parkinson's DiseaseDevice
Counseling provided to participant by site clinician/physician/genetic counselor.
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of Parkinson's related genetic mutations in an convenience cohort
Identify people with Parkinson's who have genetic mutations to advance basic science and clinical research.
Measured: 6 months
Educating people with Parkinson's of their genetic mutation status through genetic testing and counseling
People who are informed of their genetic status may be empowered to learn more about their disease and participant in clinical research.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Aug 2021
- Study start20 Dec 2020
- Primary completion1 Jul 2027 (estimated)
- Study completion1 Jul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson's DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 35,382 participants (estimated)
- Target duration
- 30 Days
Sponsor and investigators
- Lead sponsor
- Parkinson's Foundation
- Sponsor type
- University, hospital or other
- Collaborators
- Indiana University, Fulgent Genetics, The Parkinson Study Group
- Responsible party
- Sponsor
- Investigators
- James Beck, PhD, Principal investigator, Parkinson's FoundationRoy N Alcalay, MS, MD, Principal investigator, Tel Aviv Sourasky Medical Center, Columbia University Irving Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04994015
- Sponsor's protocol ID
- PDGENE-PF
- Status last verified
- Sep 2026
- First submitted
- 29 Jul 2021
- Last updated
- 8 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Parkinson's Foundation PD GENEration Genetic Registry
- ClinicalTrials.gov ID
- NCT04994015
- Acronym / sponsor ID
- PDGENE-PF
- Conditions
- Parkinson's Disease
- Keywords
- Genetics, Genetic Counseling, Whole Genome Sequencing
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 35,382 participants (estimated)
- Lead sponsor
- Parkinson's FoundationUniversity, hospital or other
- Collaborators
- Indiana University, Fulgent Genetics, The Parkinson Study Group
- Study start
- 20 Dec 2020 (actual)
- Primary completion
- 1 Jul 2027 (estimated)
- Study completion
- 1 Jul 2027 (estimated)
- First posted
- 6 Aug 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Development of a central repository for PD-related genomic data for future research.
Detailed description
The purpose of this study is to develop a central repository for PD-related genomic data by individuals who consent to deposit their data and bank their residual DNA obtained through clinical genetic testing for future research use.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Target follow-up
- 30 Days
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Any person with probable diagnosis of Parkinson's disease according to the Movement Disorders Society criteria.
Key inclusion criteria (7 listed)
- Study Population 1: PWP (open for recruitment)
- Study Population 2: People at risk of developing PD (not open for recruitment)
- 1. Family members of Study Population 1 may be invited to participate in the study if confirmatory genetic testing is deemed necessary by the genetic testing laboratory.
Key exclusion criteria (5 listed)
- Diagnosis of an atypical parkinsonian disorder (i.e., multiple system atrophy, progressive supranuclear palsy, dementia with Lewy bodies, corticobasal syndrome), including that due to medications, metabolic disorders, encephalitis, cerebrovascular disease, or normal pressure hydrocephalus.
- Individuals who have received a blood transfusion within the past 3 months.
- Individuals who have active hematologic malignancies such as lymphoma or leukemia.
- Individuals who have had a bone marrow transplant within the past 5 years.
- Under the age of 18
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Lab Assay for seven genetic variants for Parkinson's DiseaseCounseling provided to participant by site clinician/physician/genetic counselor. | Device | – |
Primary outcome
Prevalence of Parkinson's related genetic mutations in an convenience cohort
Time frame: 6 months
Identify people with Parkinson's who have genetic mutations to advance basic science and clinical research.
Educating people with Parkinson's of their genetic mutation status through genetic testing and counseling
Time frame: 6 months
People who are informed of their genetic status may be empowered to learn more about their disease and participant in clinical research.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Sep 2026.
Related trials for Parkinson's Disease
Not yet recruiting
Non-invasive Vagus Nerve Stimulation for Parkinson's Disease
Idiopathic Parkinson Disease
RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
Parkinsons Disease (PD)
RecruitingPhase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Parkinson's Disease, Dementia
Not yet recruiting
Cognitive-Motor Training for Gait Adaptability in Parkinson Disease
Parkinson Disease
Recruiting
Strength and Dual-Task on Sarcopenia in People With Parkinson's Disease
PARKINSON DISEASE (Disorder), Parkinsonism or Parkinson's Disease Nos
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
James Beck, PhD principal investigator
Parkinson's Foundation
Roy N Alcalay, MS, MD principal investigator
Tel Aviv Sourasky Medical Center, Columbia University Irving Medical Center
70 sites in 3 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Parkinson's Disease, run by Parkinson's Foundation at 70 sites in 3 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 8 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 70 sites in United States, Canada, Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Kamalini Ghosh, MS (1-800-473-4636, kghosh@parkinson.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of Parkinson's related genetic mutations in an convenience cohort (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2026.